Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
116.36
107.11
97.80
96.04
88.18
91.14
83.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
116.36
107.11
97.80
96.04
88.18
91.14
83.84
Raw Material Cost
7.84
8.15
5.66
8.71
6.66
6.54
8.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
41.01
41.45
37.58
33.62
31.09
29.70
27.23
Other Expenses
1.38
1.32
1.32
1.44
1.43
1.35
1.35
Total Expenditure (Excl Depreciation)
62.67
62.83
56.43
56.73
52.01
49.76
48.91
Operating Profit (PBDIT) excl Other Income
53.7
44.3
41.4
39.300000000000004
36.2
41.4
34.900000000000006
Other Income
7.75
6.86
6.59
7.47
7.42
7.23
7.34
Operating Profit (PBDIT)
63.17
52.89
49.58
48.32
45.23
50.20
43.76
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-12.50
Gross Profit (PBDT)
108.51
98.95
92.14
87.33
81.52
84.60
75.67
Depreciation
1.73
1.76
1.61
1.54
1.63
1.59
1.49
Profit Before Tax
61.44
51.13
47.97
46.77
43.60
48.61
29.77
Tax
5.51
-0.27
-31.40
8.44
7.86
3.13
2.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
55.93
51.40
79.36
38.33
35.73
45.48
27.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
55.93
51.40
79.36
38.33
35.73
45.48
27.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
55.93
51.40
79.36
38.33
35.73
45.48
27.18
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,276.73
1,219.56
1,137.88
1,040.65
984.67
946.38
885.85
Earnings per share (EPS)
1.83
1.7
2.66
1.29
1.2
1.52
0.91
Diluted Earnings per share
1.83
1.7
2.66
1.29
1.2
1.52
0.91
Operating Profit Margin (Excl OI)
46.14%
41.33%
42.3%
40.93%
41.02%
45.4%
41.67%
Gross Profit Margin
54.29%
49.38%
50.69%
50.31%
51.29%
55.08%
37.28%
PAT Margin
48.07%
47.99%
81.15%
39.91%
40.52%
49.9%
32.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 31.97% vs 94.70% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 56.58% vs 3,866.67% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 46.56% vs 410.81% in Mar 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Krystal Biotech, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
116.36
191.20
-74.84
-39.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
116.36
191.20
-74.84
-39.14%
Raw Material Cost
7.84
17.09
-9.25
-54.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
3.09
-3.09
-100.00%
Selling and Distribution Expenses
41.01
184.32
-143.31
-77.75%
Other Expenses
1.38
4.95
-3.57
-72.12%
Total Expenditure (Excl Depreciation)
62.67
253.97
-191.30
-75.32%
Operating Profit (PBDIT) excl Other Income
53.69
-62.77
116.46
185.53%
Other Income
7.75
1.91
5.84
305.76%
Operating Profit (PBDIT)
63.17
-58.49
121.66
208.00%
Interest
0.00
3.09
-3.09
-100.00%
Exceptional Items
0.00
-0.59
0.59
100.00%
Gross Profit (PBDT)
108.51
174.11
-65.60
-37.68%
Depreciation
1.73
2.37
-0.64
-27.00%
Profit Before Tax
61.44
-64.54
125.98
195.20%
Tax
5.51
0.00
5.51
Provisions and contingencies
0
0
0.00
Profit After Tax
55.93
-64.54
120.47
186.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
55.93
-64.54
120.47
186.66%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.93
-64.54
120.47
186.66%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,276.73
54.59
1,222.14
2,238.76%
Earnings per share (EPS)
1.83
-1.26
3.09
245.24%
Diluted Earnings per share
1.83
-1.26
3.09
245.24%
Operating Profit Margin (Excl OI)
46.14%
-32.83%
0.00
78.97%
Gross Profit Margin
54.29%
-32.52%
0.00
86.81%
PAT Margin
48.07%
-33.76%
0.00
81.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.64 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 8.68% vs 9.51% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 31.97% vs 94.70% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.59 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 8.75% vs -35.26% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 56.58% vs 3,866.67% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.54 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 20.43% vs 6.98% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 46.56% vs 410.81% in Mar 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 46.14%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
